MRK (STOCKS)
Merck & Co., Inc.
$120.299900
-1.120100 (-0.92%)
Prev close: $121.420000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Robert M. Davis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $296,983.73M
- Employees
- 75,000
- P/E (TTM)
- 16.68
- P/B (TTM)
- 5.71
- Dividend Yield
- 273.43%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $65.01B |
| Benefits Costs and Expenses | $43.94B |
| Cost Of Revenue | $16.38B |
| Costs And Expenses | $43.94B |
| Gross Profit | $48.63B |
| Operating Expenses | $27.56B |
| Selling, General, and Administrative Expenses | $10.73B |
| Research and Development | $15.79B |
| Other Operating Expenses | $1.04B |
| Operating Income/Loss | $21.07B |
| Income/Loss From Continuing Operations After Tax | $18.26B |
| Income/Loss From Continuing Operations Before Tax | $21.07B |
| Income Tax Expense/Benefit | $2.80B |
| Income Tax Expense/Benefit, Current | $4.48B |
| Income Tax Expense/Benefit, Deferred | -$1.67B |
| Net Income/Loss | $18.26B |
| Net Income/Loss Attributable To Noncontrolling Interest | $9.00M |
| Net Income/Loss Attributable To Parent | $18.25B |
| Net Income/Loss Available To Common Stockholders, Basic | $18.25B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $7.30 |
| Diluted Earnings Per Share | $7.28 |
| Basic Average Shares | 2,502,000,000 |
| Diluted Average Shares | 2,507,000,000 |
| Assets | $136.87B |
| Current Assets | $43.52B |
| Inventory | $6.66B |
| Other Current Assets | $36.86B |
| Noncurrent Assets | $93.35B |
| Fixed Assets | $25.32B |
| Intangible Assets | $26.68B |
| Other Non-current Assets | $41.35B |
| Liabilities | $84.20B |
| Current Liabilities | $28.33B |
| Accounts Payable | $4.40B |
| Other Current Liabilities | $23.92B |
| Noncurrent Liabilities | $55.88B |
| Equity | $52.66B |
| Equity Attributable To Noncontrolling Interest | $56.00M |
| Equity Attributable To Parent | $52.61B |
| Liabilities And Equity | $136.87B |
| Net Cash Flow From Operating Activities | $16.47B |
| Net Cash Flow From Operating Activities, Continuing | $16.47B |
| Net Cash Flow From Investing Activities | -$13.74B |
| Net Cash Flow From Investing Activities, Continuing | -$13.74B |
| Net Cash Flow From Financing Activities | -$1.92B |
| Net Cash Flow From Financing Activities, Continuing | -$1.92B |
| Exchange Gains/Losses | $563.00M |
| Net Cash Flow | $1.37B |
| Net Cash Flow, Continuing | $809.00M |
| Comprehensive Income/Loss | $18.91B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $18.91B |
| Other Comprehensive Income/Loss | $658.00M |
| Other Comprehensive Income/Loss Attributable To Parent | $658.00M |